Jpmorgan Chase & CO Anika Therapeutics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 82,491 shares of ANIK stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,491
Previous 15,509
431.89%
Holding current value
$1.47 Million
Previous $383,000
254.31%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ANIK
# of Institutions
113Shares Held
11.3MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.02MShares$36.1 Million4.19% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA765KShares$13.7 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY700KShares$12.5 Million3.96% of portfolio
-
Dimensional Fund Advisors LP Austin, TX657KShares$11.7 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $261M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...